secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001636422-25-000143
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q3 revenue flat at $76.3M; net loss widens 51% to $22.2M
------------------------------------------------------------------------

- Total revenue $76.3M, flat YoY; gross margin 39%, up from 36%.
- Net loss $22.2M, widened 51% from $14.7M in Q3 2024.
- Adjusted EBITDA $12.0M; results beat quarterly guidance on both revenue and EBITDA.
- FY 2025 guidance reaffirmed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642225000143/0001636422-25-000143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642225000143/hcat-20251110.htm
  HTML page:      https://secwatch.observer/filing/0001636422-25-000143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer